Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease Trial Phase 3 Completed May 12, 2026
North American Prodromal Synucleinopathy Consortium Stage 2 Trial N/A Enrolling by invitation May 12, 2026
A Study to Evaluate the Efficacy and Safety of Monosialotetrahexosylganglioside Sodium Injection in Parkinson's Disease Participants With Motor Fluctuations Trial Phase 2 Not yet recruiting May 12, 2026
New Clinical Rehabilitation Approach for the Management of Falls Risks Trial N/A Completed May 11, 2026
Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease Trial N/A Completed May 11, 2026
AID-FOG: Artificial Intelligence-Driven Freezing of Gait Detection in the Home Trial N/A Recruiting May 11, 2026
Pain in Parkinson's Disease: Exploration of the Serotonin System in Positron Emission Tomography (PET [18F]-MPPF) Trial N/A Recruiting May 10, 2026
Prevention of Medical, Social, and Psychosocial Risks Following a Parkinson's Disease Diagnosis: A Pilot Study Trial N/A Not yet recruiting May 10, 2026
Patient-Specific 3D Action Observation Training in Parkinson's Disease Trial N/A Recruiting May 10, 2026
This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease. Trial Phase 1 Recruiting May 10, 2026
Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study) Trial N/A Completed May 7, 2026
Safety and Feasibility of Tele-supervised Home-based Transcranial Direct Current Stimulation in Parkinson's Disease Trial N/A Completed May 7, 2026
Impact of Force Control of Hip Abductor Muscles in Healthy Adults and Individuals With Parkinson's Disease Trial N/A Recruiting May 7, 2026
Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder Trial Early Phase 1 Recruiting May 7, 2026